Patients with positive E-cadherin expression exhibit a lower risk of metastasis (Figure 6A, p = 0.013) and better overall survival rate (Figure 6B, p = 0.047) than do those with negative E-cadherin expression in 14-3-3ε positive HCC tumors. This evidence concerns the gene CDH1 and hepatocellular carcinoma.